Board of Directors
Company Risk
The Company may face risks if negative impacts occur to such products, particularly the fluctuations in sales of such products, which depend on several factors beyond the Company's control, such as changes in consumer behavior and trends, declining brand popularity, increased competition, substitute products, economic slowdown, as well as the dissemination of false negative information about the products, etc., which could negatively impact the Company's business, operating results, and financial position.
To mitigate this risk, the Company continuously conducts marketing activities to build brand awareness and confidence in its products, thereby maintaining product sales and market share. Furthermore, the Company consistently develops new products to enhance diversity and mitigate the risk of over-reliance on any single product. Specifically: 1) The Company regularly launches new products, as each type of dietary supplement has a distinct Product Life Cycle, to prevent excessive dependence on revenue from any single product. This also involves developing dietary supplement ingredients to ensure maximum consumer benefit. 2) The Company implements marketing campaigns to stimulate sales. And 3) the Company employs a co-selling strategy for its products with celebrities, artists, actors, singers, or influencers, sharing benefits to boost sales and expand product awareness. Overall, the Product Life Cycle of the Company's products typically spans 2-3 years (measured by sales value of 10% or more, sustained for 2-3 years). Throughout the Product Life Cycle, the Company develops new formulations for existing products. This involves enhancing formulas by adding extracts or increasing beneficial properties, such as various 'Plus' formulas, which contributes to the continued acceptance of the Company's products. The Product Life Cycle of key products with sales exceeding 10% in 2025 can be described as follows: - The Yes Care product began production and was launched in capsule form in mid-2019. Initially, it did not gain popularity among consumers, as they felt it resembled medication, even though the capsules were odorless. Consequently, in 2020, the Company conducted further research, and by late 2021, it launched Yes Care in tablet form, adding a blueberry scent to make it more appealing and less like medication. Based on market research, the Company believes Yes Care will gain popularity as it is an eye and vision-related product, suitable for individuals who extensively use their eyes for work involving computers and mobile phones. In mid-2022, the Company engaged Ms. Yui-Jiranun Manochaem as a presenter to advertise/promote the product. Also in mid-2022, the Company entered into a profit-sharing agreement with Ms. Yui, which has been continuously renewed to date. By the end of 2024, the Company anticipates that the Product Life Cycle of Yes Care will not increase significantly, leading the Company to develop the Yes Care Plus formula with enhanced ingredients. - The Alfa Chlorophyll product was developed by the Company to balance the digestive system and supplement intestinal fiber, launching in 2018. In early 2022, the Company engaged influencers, including Khun Eed-Ponglang, to advertise and promote the product. By late 2022, the Company hired Khun Mark-Prin as a presenter. Subsequently, from late 2023 to the present, the Company has engaged Khun Mawin Taweepol and Khun Tu Piyawadee as presenters. As shown in the table, the Product Life Cycle of Alfa Chlorophyll in 2022 saw it achieve the highest sales, which began to decline in 2023. Therefore, in 2023, the Company developed four additional Alfa Chlorophyll formulas, which are 'Plus' formulas containing enhanced ingredients. - Regarding 2025, the Astaxia 14 Complex product achieved sales exceeding 10% in 2025. In November 2023, the Company developed this product, containing cold-pressed oils and 14 key ingredients, targeting individuals with high blood lipid issues affecting blood pressure and providing antioxidant benefits. This was done in collaboration with actor Mr. Siwat Chotchaicharin, also known in the entertainment industry as Khun C Siwat, with whom a profit-sharing agreement was made. The product was first launched in February 2024. In 2025, sales revenue from Astaxia 14 Complex moved up to the 2nd position, from 3rd position in 2024. Additionally, in 2025, the Company developed three new product formulas under the CMF brand, which were launched in late 2025.
From the above data for 2022-2024 and 2025, it is evident that the company relies primarily on sales channels, especially the Facebook platform. Furthermore, in 2025, the company also relies on the TikTok channel. The company sells dietary supplements and cosmetics through online channels such as Facebook, TikTok, Lazada, and Shopee platforms. The company began implementing a strategy to focus on selling both dietary supplements and cosmetics through online channels in 2022 and has continuously developed and expanded this approach to the present. From 2022 to 2025, the company's revenue from online sales accounted for 44.20%, 59.50%, 69.40%, and 76.90% of total sales revenue, respectively. Additionally, sales through the Facebook platform accounted for an average of approximately 62.4% of online sales revenue over a three-year period. This poses a risk to the company should the aforementioned platform lose popularity, potentially leading to a loss of revenue. However, with current consumer behavior, there are more options for purchasing the company's various products through a wider range of channels. The company endeavors to sell products through various channels to cover consumer needs as comprehensively as possible. This is to reduce reliance on any single revenue channel, for which the company has consistently monitored consumer behavior. Furthermore, the company has implemented proactive sales operations, including providing after-sales services that extend from internal processes to external customer engagement. To foster repeat purchases of the company's products, based on the analysis of the company's customer database.
The company has a plan to increase sales revenue through alternative channels to reduce its reliance on online channel revenue, particularly from the Facebook platform. This involves specifically focusing on selling products in each channel, such as through the TV Home Shopping channel under the ALOKAA brand and the pharmacy (OTC) channel under the PNCP brand, among others.
The company therefore faces a risk if the aforementioned presenter subsequently gains a negative reputation, as it will also affect the company's products. Furthermore, if the presenter of the company's main product can effectively communicate or represent the product, but due to the annual contract renewal, if the said presenter does not renew the contract with the company, it could also impact the company's revenue. The company has products in the dietary supplement category, which constitute the company's main revenue. One such dietary supplement product is Yes Care, featuring Ms. Jeeranun Manochaem, also known in the entertainment industry as Khun Yui Jeeranun, as its presenter. The company's revenue from this product in 2025 accounted for 37%, and in 2023-2024, it accounted for 40% of sales revenue (with the same proportion for both years). For 2022, the revenue accounted for 10% of sales revenue. The revenue from this product was significantly important to the company from 2023 to 2025. Additionally, the company also has the product Astaxia 14 Complex, featuring Mr. Siwat Chotchaicharin, also known in the entertainment industry as Khun C-Siwat, as its presenter. The company's revenue from this product in 2025 accounted for 19% of sales revenue, and the sales revenue from Astaxia 14 Complex is also considered significant to the company. The customer feedback is considered to be in line with targets, allowing the company to assess whether its offerings meet customer needs. If the results meet the targets, the company will renew the presenter's contract. If the targets are not met, the company will seek a new presenter.
The company mitigates risks by engaging presenters. The company considers the following factors for selecting presenters: (1) Possesses a character that aligns with the target customer group, (2) Has a customer base that matches the company's product target group and possesses their own distribution channels, (3) Has a presentation style suitable for the application of the company's products, (4) Enjoys market popularity and is well-known in society, and (5) Maintains a good and appropriate image. For the renewal of presenter contracts, the company conducts an annual review to assess customer reception. Nevertheless, the company has continuously renewed contracts with the presenters of its main products every year until the present, since the initial contract in May 2022.
Such advertising may carry the risk of disseminating insufficient information or warnings, or misleading claims of exaggerated properties. The company has engaged presenters or influencers, as agreed upon by both parties, to assist in presenting the company's products. This includes online sales channels where the company operates Facebook pages and official accounts on platforms such as TikTok, Shopee, Lazada, and Line, totaling approximately one thousand Facebook pages and official accounts. Due to the numerous Facebook pages and official accounts across various channels, ensuring compliance with the company's advertising procedures by employees and communicating advertising requirements to presenters or influencers may not cover all channels on the company's online platforms. Consequently, there is a risk that the company may be subject to fines and advertisement suspensions by the FDA. In the past, from 2022 to 2025, the company received 36 letters ordering the suspension of advertisements. [In 2021, the company did not receive any letters from the FDA ordering the suspension of advertisements or demanding fines, as the company did not focus on online sales channels in 2021 (in 2021, the company's online revenue was 15%). The reason the company received letters ordering advertisement suspensions was due to the misunderstanding that advertisements claiming product benefits did not require authorization, which was an incorrect understanding, and these were old posts remaining in the system. Approximately 65% of these suspended advertisements were for Yes Care products, and the suspended advertisements originated from Facebook pages. A summary is as follows:] Item | Amount of Fine | Reasons for advertisement suspension orders (due to posts) Exaggerated advertising | Not authorized before advertising 10 cases | 0.16 million Baht | 2 cases / fine of 0.09 million Baht (cosmetics) | 8 cases / fine of 0.07 million Baht (dietary supplements) 26 cases | - | - | 26 cases (dietary supplements) (no comparative fine letter) Total 36 cases | Total 0.16 million Baht | 2 cases / fine of 0.09 million Baht. | 34 cases / fine of 0.07 million Baht. Impact (Advertising offenses) | - Advertising cosmetics with false or exaggerated statements is punishable by imprisonment not exceeding 1 year, or a fine not exceeding 100,000 Baht, or both (fine for the company and the managing director). - The company has fully paid the fine, and the matter is considered concluded. | - Advertising food without prior authorization is subject to a fine not exceeding 5,000 Baht. - The company has fully paid the fine, and the matter is considered concluded. Remedial Measures | - The company has instructed employees to comply with "Work Procedures for Controlling Content Operations to comply with FDA announcements." | - The company has instructed employees to comply with the "Advertising Media Production" regulations, which specify the types of advertisements that require prior authorization from the FDA.
The company has stipulated that all advertisements across all channels must obtain prior approval from the Food and Drug Administration before publication. The company has submitted applications for food advertising permits through the e-submission system for convenience and speed in document submission. Therefore, it can be concluded that, as of now, the company has obtained food advertising permits for all formats, including online product sales and television home shopping (TV Home Shopping), which is an offline sales channel, as well as product-specific advertising (By Product). Currently, the company has established operational manuals for advertising media production and content creation control to comply with FDA announcements. Since late November 2024 until now, the company has not received any letters from the FDA regarding advertising matters. Regarding the news of a warning on the FDA's website concerning the dietary supplement Yes Care, which appeared as a warning on the website of the Food and Drug Administration ("FDA") regarding false advertising of the benefits, quality, or properties of the dietary supplement "Yes Care" dated August 20, 2024, the company has investigated and found that it was a fake Facebook page. The company has not received any official documents from government agencies stating that the company has committed any wrongdoing. The company has attempted to inquire with the agencies about the letter to be sent to the company for proper action, but has not received any letter from government agencies. For the warning message on the FDA's website, the company has already reported it to online platforms for the third-party Facebook pages. The messages displayed on the company's online advertising platforms still contain content similar to what the FDA warned the company about. As a result of the lingering warning messages, the content may still not comply with FDA regulations. The company has already deleted or blocked visibility (Clean Page) on its Facebook page and official accounts on Tik Tok, Shopee, Lazada, and Line platforms. The company has mandated that the Board of Directors be informed quarterly of the actions taken to delete or block visibility (Clean Page). Furthermore, if consumers complain to the FDA about exaggerated advertising of dietary supplements, it could impact the company's reputation, potentially causing consumers to delay orders and affecting the company's revenue, especially for Yes Care products, which generated 9.60%, 39.80%, 40.20%, and 37.20% of sales revenue in 2022-2025, respectively. If the company is ordered to suspend the production of Yes Care products due to complaints to the FDA and the FDA orders a production suspension, in the worst-case scenario, the company would lose approximately 37.2% of its total sales revenue from Yes Care products, which would not result in a net loss for the company. However, the company has a continuous plan to develop and launch new products to replace Yes Care products that may be subject to production suspension. However, the company is aware and has implemented control and monitoring measures as follows: - The company controls exaggerated advertising by establishing work procedures and operational controls for content creation to comply with the Food and Drug Administration's announcements. Key aspects include: (1) A script content review process to verify data accuracy in accordance with the FDA's advertising criteria. (2) The company's assigned personnel must communicate and explain the script content to influencers or contractors for their acknowledgment and compliance, including obtaining their signed acknowledgment. In cases where a notification letter is received from the FDA, the company will consider it a factor in future employment decisions. - Regarding live content creation to comply with the Food and Drug Administration's announcements, the department head or assigned person is required to present a summary of the script content to the contractor (Influencer / KOL) to explain the script content. The contractor must sign the script content summary to acknowledge and comply with the reviewed summary provided by the company. This serves as notification for the contractor to adhere to the guidelines. In the event of a lawsuit from the FDA, the company will consider this in future employment decisions regarding that contractor. - For live broadcasts on the company's Facebook page, company employees will conduct the live sessions, and these employees will receive training on avoiding exaggerated statements. For influencers, they will conduct live sessions on their own channels. The company has established script content review measures to verify data accuracy and requires influencers or contractors to sign an acknowledgment. To date, the company has not incurred any fines from live broadcasts. - Advertising Media Production (The company has established operational procedures for the Production team to carry out assigned activities, and the preparation of information for advertising media must comply with the Food and Drug Administration's announcements regarding food advertising criteria, taking into account the conditions for submitting food advertising permit applications, which require obtaining a food advertising permit before any advertisement is published, to ensure compliance with FDA regulations.) - The company has enhanced control measures by establishing a Work Instruction detailing procedures for dealing with fake Facebook pages, counterfeit products, or fake accounts on Tik Tok, Shopee, Lazada, and Line platforms. This instruction outlines the operational methods for the sales operations department to follow when detecting fake Facebook pages or fake accounts on Tik Tok, Shopee, Lazada, and Line platforms, and when counterfeit products are found. This involves, for various online sales channels, initiating chats on those fake Facebook pages and accounts to place product orders. Upon receiving the products, they will be sent to the New Product Development Department for inspection. If the product is found to be from a fake Facebook page, a fake account, or is a counterfeit product, the company will gather evidence to take legal action if it is a counterfeit product. Additionally, the company will report the fake Facebook page and account on the respective online platforms for the platforms to take action, along with submitting supporting documents to confirm that the company's official Facebook page and official accounts are genuine. Regarding monitoring measures, the company has continuously implemented them to ensure compliance with the control measures established throughout the process to prevent exaggerated advertising of dietary supplements beyond what is permitted by the Food and Drug Administration. These measures include: 1) Operations and controls for advertising and permit applications according to the revised advertising procedures, approved by the Board of Directors' Meeting No. 2/2568 on February 13, 2568 (2025). This stipulates that information prepared for advertising media must comply with FDA announcements, requiring a final verification of words or messages before submitting an advertising permit application. And 2) Controls after obtaining permission (to ensure compliance with the granted permission). The company has established work procedures for controlling content creation operations to comply with the revised Food and Drug Administration announcements, approved by the Board of Directors' Meeting No. 1/2568 on January 13, 2568 (2025). This requires assigned personnel to communicate with contractors to explain the script content, and contractors must sign the script content summary to acknowledge and comply with the reviewed summary provided by the company. This serves as notification for the contractors to adhere to the guidelines. Internal auditors are assigned to audit compliance with the internal control system for these two matters.
The company may be affected by fake online social media or the detection of counterfeit products, which could impact the company's image, as well as the brands of both dietary supplements and cosmetics.
The company mitigates risks through the following methods: The company has established operational procedures regarding guidelines for dealing with fake Facebook pages and fake accounts on Tik Tok, Shopee, Lazada, and Line platforms, or when counterfeit products are detected. The key content is that in such cases, the company will report to each sales channel. This reporting to each sales channel is to inform them that the company has found fake account owners (Tik Tok, Shopee, Lazada, and Line), fake Facebook pages, or counterfeit products. Additionally, the company has submitted documents to each sales channel to confirm that its Facebook page or company account is authentic. Currently, the company has not found any fake Facebook pages or fake account owners on the Shopee and Lazada platforms. Regarding monitoring measures, operational staff monitor fake Facebook pages or fake account owners weekly and report on this monitoring monthly at Board of Directors meetings. In the case of Facebook platform channels where orders are placed without going through the central system of each platform, the company will assign its employees to purchase products from those fake Facebook pages to collect evidence of the purchase, seller, shipper, and recipient of funds. Once the product is received, it will be sent to the New Product Development department to verify whether it is a genuine company product. If it is a counterfeit, evidence will be collected, and legal action will subsequently be pursued.
If the company fails to develop new products that meet evolving consumer demands or maintain product quality standards, it may be unable to retain its existing customer base for repeat purchases. Furthermore, the company may not acquire new customers, which could impact its profitability in the long term. The dietary supplement business can be categorized into three types: (1) Manufacturing, (2) Distribution, and (3) Manufacturing and Distribution. NUT operates in the manufacturing and distribution of dietary supplements, which constitutes the company's primary revenue. According to data from the Department of Industrial Works, based on TSIC code 21001 as of December 31, 2025, there are a total of 376 factories capable of producing pharmaceuticals and dietary supplements. As for the cosmetics business, it can also be categorized into three types: (1) Manufacturing, (2) Distribution, and (3) Manufacturing and Distribution. NUT operates in the manufacturing and distribution of cosmetic products. According to the Cosmetics Sales Business Analysis from Krungthai Compass as of November 14, 2024, there were more than 9,000 cosmetic entrepreneurs in 2025. Currently, the number of entrepreneurs entering this business has increased due to low investment requirements or the option of outsourcing manufacturing to factories. This has led to a significant number of competitors in the dietary supplement and cosmetics markets.
The company is aware of such risks and therefore prioritizes product quality and the development of new products suitable for each customer segment. The company has a New Product Development (NPD) department to develop products that align with the needs of target customers, based on customer data from the sales department and market information, competitor and industry analysis, and team meetings with executives, to obtain products that can better meet consumer needs. The company continuously introduces new products to the market to reduce reliance on any single product. New products are also entered into international competitions, and the awards received are used for public relations in conjunction with products related to the research, to enhance customer confidence and awareness. Most recently, the company received a silver medal from an international event in Switzerland at The 49 th International Exhibition of Inventions Geneva in Geneva, for the Yes Care research award, a dietary supplement for eye and vision nourishment. This involves a marigold flower extraction process, which has undergone optometric testing with ophthalmologists. Furthermore, increasing distribution channels to make products easily accessible to consumers, advertising across various media, and selecting well-known presenters who can reach the target audience are employed to enhance product recognition. The company also employs a co-branding marketing strategy, which involves creating a new brand with a contractual partner, jointly marketing it, and sharing benefits. For example, the Astaxia 14 dietary supplement under the CMF trademark. This is considered a collaboration with a product presenter partner to stimulate the company's sales growth.
may negatively impact the company's business, operating results, financial position, and business opportunities.
The company prioritizes the introduction of new products to the market for business growth. Therefore, the company continuously develops new products for the market, including both its dietary supplements and cosmetic products. Upon successful product development in a given year, the company has products that are both produced and sold within that year, as well as products that are not produced within that year, summarized as follows: - Year 2022: The company developed 52 types of products in 2022. Of these, 39 types of products were developed but not produced in 2022, representing 75% of product development in 2022. - Year 2023: The company developed 75 types of products in 2023. Of these, 50 types of products were developed but not produced in 2023, representing 67% of product development in 2023. - Year 2024: The company developed 127 types of products in 2024. Of these, 98 types of products were developed but not produced in 2024, representing 77% of product development in 2024. - Year 2025: The company developed 74 types of products in 2025. Of these, 44 types of products were developed but not produced in 2025, representing 59% of product development in 2025. Regarding the products manufactured and sold by the company from 2022-2025, there were only approximately 1-3 "Hero Products" each year. The company's operations encompass gathering customer requirements by the sales department, collecting market demand data by the marketing department, and then convening meetings with the New Product Development (NPD) department to identify pain points and solutions related to product trends. Furthermore, meetings are held with management to generate new product concepts, as well as to conduct risk and investment analyses. Once approved, the NPD department develops the new product and calculates the determined cost (Factory Price). After initial new product development, coordination is made with the supply chain department to obtain information regarding raw materials and production capacity. Coordination is also made with the Product Design team to ensure product design aligns with customer needs. During this phase, newly developed products are tested with target customer groups to gather feedback, refine the products, and prepare them for market launch. Additionally, the company maintains good relationships with its partners, regularly sharing industry trend information. However, the company is aware of these risks. The company has a New Product Development (NPD) department that receives information from the sales and marketing departments regarding consumer needs. This is done by surveying consumer needs through both social media and market research. The requirements are then sent to the NPD department to innovate production formulas and calculate costs. Once a product is developed, it is tested with target consumers before launch. Based on the company's experience, products can be launched promptly to meet market demand at that time. Furthermore, the company sets discounts to reduce selling prices to a level not lower than the cost price, categorized by product group, primarily considering profitability and business performance. The company also develops promotional activity plans, defining objectives, targets, and activity durations, with approval based on the authorization matrix. For products aged 3 months or more, if the company determines a product has potential, it will manage it by offering promotions or complimentary items. For products aged 6 months or more, the company expedites the sale of these items within 3 months. In advertising planning, the company has a Content department responsible for content creation (developing brand-related content) and producing advertising media. Additionally, the company has a Sales Operation department responsible for producing static advertising media and engaging influencers to promote products. The company monitors revenue from advertising campaigns and prepares monthly reports summarizing advertising expenses and sales, which are presented to management. This involves monitoring advertising campaign costs against sales to ensure they remain within company-defined criteria and contribute to increased company sales. The company conducts market research before product launch, and after product launch, it organizes promotions to boost sales and stimulate demand.
The company has capital tied up in these PM and RM. This also leads to expenses for storage and maintenance to keep them in usable condition. Furthermore, if the PM and RM are found to be unusable upon inspection, the company will incur disposal costs.
The company has established guidelines to prevent risks in this matter by requiring relevant departments to prepare reports on long-standing RM (Raw Materials) and PM (Packaging Materials) (previously, the company only prepared FG (Finished Goods) reports) to develop a stock clearance plan. The sales department prepares sales forecasts in collaboration with the marketing and production departments to plan production, with management participation. The company has established measures for managing long-standing inventory, which require reporting on the implementation and monitoring of these measures to the Executive Board meeting monthly and to the Audit Committee meeting quarterly. According to the RM and PM clearance plan, this results in an increased estimate for inventory valuation allowance due to the company having long-standing inventory. A summary as of December 31, 2025, is presented in the table below: (Unit: Million Baht) Inventory type | Period | Remaining value As of December 31, 2025 | Actual usage (Jan-Mar 2025) | Production plan (Apr-Dec 2025) | Remaining value After withdrawal and production plan | Additional inventory provision in the next step | Note (% additional provision) Packaging Materials (PM) | 731 – 1,095 days | 5.49 | (0.72) | (1.40) | 3.37 | 0.51 | 15% Packaging Materials (PM) | 1,096 – 1,460 days | 4.59 | (0.37) | (0.37) | 3.86 | 0.96 | 25% Packaging Materials (PM) | 1,461 – 1,825 days | 4.48 | (0.19) | (0.28) | 4.01 | 2.01 | 50% Packaging Materials (PM) | Total | 14.57 | (1.28) | (2.04) | 11.25 | 3.48 | Raw Materials (RM) | 365 – 730 days | 3.81 | (0.21) | (1.57) | 2.02 | 1.01 | 50% Grand Total | 18.38 | (1.49) | (3.62) | 13.27 | 4.49 | From the data in the table above, it is evident that the company has considered increasing its estimated inventory valuation allowance by 4.49 million baht, from the original 23.95 million baht, which was set according to the company's policy for estimating allowances. The increase of 4.49 million baht is due to the company's actual withdrawals and production plan not covering the remaining RM and PM values at the end of the period. Therefore, the company decided to set an additional allowance in the next step. The production plan aligns with the company's sales plan, which was approved by the Executive Board meeting in March 2025. In this production plan for clearing RM and PM, the production of dietary supplements uses the original formulation already approved by the FDA, with the FDA registration number specified on the original packaging that the company plans to clear. The production of cosmetic products uses a new formulation that the company has recently received FDA approval for, according to the raw material (RM) clearance plan. For packaging or PM, the company uses the original PM, except for new labels. Examples of cosmetic products include shampoo, hair conditioner, and hair care products. For products with rapidly changing popularity, or those with uncertainty regarding market success, or during periods of changing economic conditions affecting demand or reduced consumption, the company may face risks from increasing aged or expired inventory, increased inventory provisions, and/or the need for promotions to accelerate inventory clearance, as well as increased inventory holding costs. Conversely, if the company has too low an inventory level, it may be due to underestimating market demand, delayed production or procurement of raw materials, or market shortages. This exposes the company to the risk of being unable to deliver goods according to customer orders, which could impact good customer relationships and potentially affect the company's business, operational results, financial position, and business opportunities. The company recognizes these risks and strives to manage inventory efficiently. The company has the following key operational processes: (1) The warehouse department provides a monthly summary of slow-moving items to the sales department. (2) Inventory items are reviewed and grouped for management, categorized into items older than 6 months to 1 year, items younger than 6 months, and items younger than 3 months. (3) Authorized personnel determine inventory management methods, such as organizing promotions, which are proposed to the company's executives for consideration, or methods for managing slow-moving items or items aged 3-12 months. Authorized personnel must submit monthly reports on the management of slow-moving items to executives at Executive Board meetings, so that the sales department can use this information to organize promotions for inventory clearance. As for goods returned to the company from various sales channels, the company will subject them to an inspection process to determine if they can be resold. This involves repackaging or changing packaging materials to sell them through online channels to reach consumers faster. Returned goods that cannot undergo the repackaging process will be sent for destruction. Past statistics show that the company has been able to repack and resell over 98% of returned goods. For Original Equipment Manufacturing (OEM), the company has set minimum production order quantities in accordance with its policy, which is communicated to the clients. In production, the company will have a plan and will check the remaining raw materials and packaging in stock to calculate order quantities that align with the OEM client's orders. Therefore, the company does not face risks regarding raw material and packaging inventory for OEM products. Finished OEM products are delivered in full to the OEM client, so there is no outstanding finished OEM inventory. However, the company's value of destroyed goods for the years 2022-2025 amounted to 3.06 million baht, 3.45 million baht, 4.95 million baht, and 5.01 million baht, respectively, representing 2.31%, 2.74%, 4.21%, and 4.89% of inventory at the end of the period, respectively. The company faces the risk of destroying goods, which may impact its revenue if these goods cannot generate income through sales or promotions from inventory management before expiration. Additionally, the company incurs expenses for destroying goods, which for the years 2022-2025 were 0.05 million baht, 0.03 million baht, 0.06 million baht, and 0.06 million baht, respectively. From a management perspective, this also leads to a loss of storage space as the company must store these goods separately awaiting destruction. These are mostly expired finished goods due to unpopularity. The company manages finished goods by notifying the sales department monthly about slow-moving items for promotional activities as mentioned above. Furthermore, the company's inventory management and destruction of goods, as mentioned above, also contribute to an increased risk in setting provisions for inventory valuation. This is due to the business of manufacturing and distributing dietary supplements and cosmetics, making inventory a significant asset that impacts the company's performance. The company must procure both raw materials and packaging materials for the production of dietary supplements and cosmetics to be sold to consumers. In conducting business, there will be products that meet the set targets or fall below them. If they fall below the targets, the company faces risks from setting provisions for inventory valuation related to dietary supplements and cosmetics. The company has methods to mitigate this risk by presenting proposals, which involve analysis and market research, with meetings held by all relevant departmental staff to plan operations. The company's procurement of raw materials and packaging will be determined to align with sales volume (Sale Forecast). Before placing orders, the company will check the remaining stock of raw materials and packaging, considering the delivery times of both domestic and international suppliers. Additionally, once production is complete and goods become finished products, the company will instruct the warehouse department to provide a monthly summary of slow-moving and non-moving items to the sales department. This is to manage inventory through promotions, thereby reducing the risk of the company having to set aside provisions for inventory valuation.
may result in the company being unable to retain its existing customer base and attract new customer segments, potentially leading to a loss of business opportunities. Furthermore, if the company cannot accurately forecast product demand, it may incur product development costs and marketing expenses that do not generate worthwhile revenue, consequently leading to the company's profit margin not meeting its established targets.
The company regularly monitors news, trends, and changes in consumer behavior and preferences, with a dedicated demand and supply planning team to ensure accurate data. This approach aims to reduce production costs associated with market oversupply and enhance profitability through flexible and efficient production. Regular meetings are conducted with relevant departments, such as sales and marketing, to gather information on promotions, sales activities, and new product launches for the preparation of weekly and monthly production plans. Furthermore, data on the demand for each type of dietary supplement and cosmetic product is optimized, and raw material and packaging material data are prepared in alignment with the company's business plan. In addition, to retain existing customers, attract new customers, and expand into new markets, the company focuses on developing and offering high-quality products that meet the needs of target consumer groups. This strategy aims to build product credibility and enhance customer satisfaction, as well as to develop and increase appropriate communication channels to provide knowledge and understanding of product features.
If the company fails to comply with relevant regulations or does not register dietary supplements as required by law, this could impact the company's reputation and operations in the future.
The company prepares legally compliant advertisements for its product presenters, such as presenters or influencers, to prevent potentially unlawful advertising. The company's products are dietary supplements and cosmetics, which are products that may affect consumers' health. Therefore, all of the company's products must be authorized, registered with relevant agencies, and comply with the laws, regulations, and supervisory guidelines of the Food and Drug Administration (FDA), Ministry of Public Health, in various aspects. For instance, dietary supplements must be registered with the Food and Drug Administration (FDA), and cosmetic products must be notified to the Food and Drug Administration (FDA). The company must also strictly adhere to the conditions of various licenses obtained for its business operations. Furthermore, product labels and advertisements must be inspected and approved by relevant agencies before products can be sold. Product labels must be displayed as prescribed by the FDA to ensure consumers can clearly read the information before making a purchase decision. It can therefore be concluded that the company has currently obtained food advertisement permits for all forms of product sales via online channels and product advertising via television channels (TV Home Shopping), an offline sales channel, as well as applying for product-specific advertisements (By Product). Furthermore, the company is a manufacturer of dietary supplements and cosmetics, whether acting as a distributor or a contract manufacturer (OEM). The company has fully obtained a food production license, a factory operation license, and a license for businesses hazardous to health for its complete business operations. Nevertheless, the company has consistently monitored various changes and closely adhered to relevant regulations, criteria, and control standards. The company has a new product development department directly responsible for registration duties, including closely monitoring news and trends regarding changes in laws, regulations, criteria, and control standards relevant to the company, so that the company can promptly prepare to cope with any upcoming changes.
The company's legal advisor is of the opinion that, should the court rule that the company must pay damages to the plaintiff, along with interest at a rate of 5% per annum from the date of filing the lawsuit, the payment of such damages is not expected to have a significant negative impact on the company's assets and will not impose any restrictions on the transfer of the company's shares. The company's financial statements as of June 30, 2024, have recognized the damages from this case in the amount of 0.30 million Baht, along with interest at a rate of 5% per annum, in accordance with the judgment of the Central Labour Court.
The legal counsel's opinion is as follows: In considering an appeal, the Court of Appeal must consider the evidence presented in the court of first instance. It cannot consider new facts and/or evidence, unless the court permits the plaintiff to submit additional new evidence. The plaintiff has a duty to satisfy the court that, after the examination of witnesses, new facts emerged which made it necessary for the plaintiff to know that there was a need to cite such new evidence, and that such new evidence (a) only arose after the completion of witness examination, (b) is crucial evidence that will lead to a fair determination of important issues in the case, and (c) is credible evidence. Therefore, if the plaintiff does not present new facts, the Court of Appeal will only consider the evidence presented by the plaintiff in the court of first instance.
The lawsuit, which is currently subject to debt repayment as per the claim, impacts operations and necessitates the recognition of expected credit losses.
The company implements risk management, which involves establishing operational procedures and monitoring debt collection to regularly review outstanding debtors on a monthly basis.
Should there be claims regarding the company's product liability, this may result in the company having to recall some or all products, withdraw products from the market, cease production, destroy remaining inventory, and lose sales from recalled products. This also includes cases where the company may be liable to pay compensation if its products cause injury, illness, or death, even if such incidents may result from damage during storage and transportation or from actions by retailers selling the company's products. In the event of the aforementioned incidents or allegations that products sold by the company are unsafe, even if such allegations are not based on facts, this could affect the company's reputation, trust, and demand for products under its brand, and may negatively impact the company's business, operating results, and financial position.
The Company is aware of such risks and has prioritized management to prevent its products from contamination, deterioration, or expiration during development, production, storage, transportation, and inventory management. This includes establishing quality control for raw materials used in production, through random quality checks of raw materials and packaging from the receiving stage, random checks of raw materials before every production lot, and random checks of products both during packaging and after becoming finished products in every production lot. Furthermore, the Company has obtained Food Safety Management System standards (ISO 22000:2018), Good Manufacturing Practices for Cosmetics standards (ISO 22716:2007), Good Hygiene Practice (GHP) standards for food production, and Hazard Analysis and Critical Control Point (HACCP) production standards. To date, the Company has not received any claims regarding product liability that significantly impact its business operations. For OEM or contract manufactured products, the Company is responsible for obtaining FDA approval as it is the manufacturing facility. Product labels clearly state allergens in all products, referencing allergens as per the Ministry of Public Health's announcements. To date, the Company has not received any complaints regarding allergens for contract manufactured products. In the event of a consumer complaint regarding products manufactured by the Company under contract (OEM), the Company bears no responsibility, as it has already listed allergens on the product labels. Consumers are required to review the information on the label as specified before consumption. Furthermore, the Company has not received any customer complaints regarding the consumption or use of its products to date.
Labor shortages or transportation issues, which the company cannot guarantee will secure raw materials in the quantity and quality required by the company, may result in the company being unable to deliver products to customers within the specified timeframe and quantity. This could negatively impact the company's business, operational performance, financial position, reputation, credibility, and business opportunities.
Recognizing these risks, the company imports raw materials for both dietary supplements and cosmetics from various companies. From 2022 to 2025, the company has not relied on any single raw material supplier exclusively. However, in 2022, the company relied on one domestic raw material supplier for 14% of its total purchase value, due to the procurement of Alfalfa, used in the production of Alfa Chlorophyll, which was a best-selling product in 2022. And in 2025, the company relied on one international raw material supplier for 7.28% of its total purchase value, due to the procurement of Astaxanthin Oil, used in the production of Astaxia 14 Complex and Asta Oil, with Astaxia 14 Complex being a best-selling product in 2025. This purchase was in line with the production plan, and the company has reduced its reliance on this particular supplier by also purchasing from other domestic suppliers. Meanwhile, the company still relies on one domestic raw material supplier for 11.51% of its total purchase value, due to the procurement of 1) Fish Collagen and 2) Astaxanthin Oil. Fish Collagen is a raw material used in the production of collagen-group dietary supplements, while Astaxanthin Oil is used in the production of Astaxia 14 Complex. The high percentage from this domestic supplier is due to the combined purchase value of these two types of raw materials. The company has diversified its risk from relying on international raw material suppliers by purchasing domestically, not for a single product/type, but for two types of raw materials from this domestic supplier, thus resulting in a high value of 11.51%. Furthermore, in 2023, 2024, and 2025, the company increased its imports of raw materials from abroad. In 2022, most raw material purchases were sourced domestically. The company's approximate proportions of domestic to international raw material purchases/imports were: 90:10 for 2022, 75:25 for 2023, 65:35 for 2024, and 63:37 for 2025, with the latter reflecting increased international raw material imports. where the company incurs lower costs than purchasing domestically. Furthermore, the company's engagement with multiple suppliers helps mitigate the risk of over-reliance on any single supplier and prevents risks associated with delayed raw material deliveries, as the company maintains relationships with other suppliers. For international orders of raw materials and packaging, the company makes immediate payments without credit terms, and some international suppliers require a 50% upfront deposit, with the remaining balance paid upon receipt of goods. This impacts the company's payment cycle and cash flow, potentially leading to liquidity issues. However, approximately 70-80% of the company's sales are conducted through online channels, where payments are mostly received immediately, thus mitigating the risk of liquidity shortages. Nevertheless, the company is currently negotiating credit terms with international suppliers. In raw material procurement, the company conducts purchasing activities considering quality, price, quantity, service, and responsiveness, prioritizing efficiency and effectiveness. It also reviews historical usage or purchase data in aggregate to negotiate prices based on tiered purchase volumes. For every purchase, the company conducts annual supplier evaluations to assess whether raw material deliveries adhere to agreed-upon schedules. Furthermore, the company develops annual purchase forecasts for all finished goods, raw materials, and packaging, based on full-year statistical reports and considering sales growth factors, production volumes from the production department, and all other relevant departments, before finalizing annual, quarterly, and monthly purchase requirements.
The company may face a risk that consumers could be misled by the product name and mistakenly believe it is the company's product.
The company mitigates this risk by affixing its registered trademark to the products, in addition to the trade name or brand name that serves as the product's designation. For example, for Veggie products, the trademark is "Wynnfarm," as the term "Veggie," meaning vegetable, is a generic term that was denied registration.
The company may be at risk of being prohibited by local authorities from using or entering any part of the building if the building occupied and used by the company has not obtained a construction permit. Furthermore, there is a risk of being ordered by local authorities to suspend the use of the part of the building that has not yet received a permit.
The Sap Rung Rueang-40 mini-factory, used by the company for producing Alpha Chlorophyll dietary supplements, and the mini-factory used by the company for producing cosmetics, are not the company's primary production facilities. The company can relocate production to the TIP9 factory, which is the company's main production facility and has sufficient space to accommodate the production of both cosmetic products and Alpha Chlorophyll dietary supplements. Furthermore, the machinery used in production consists only of mixing equipment, and other production steps are not complicated or complex. The Alpha Chlorophyll production facility is owned by the company, and thus the company has no rental payment obligations. The cosmetic production facility is leased by the company for a period of 2 years, with the lease agreement renewed every 2 years, meaning the company is not bound by a long-term contract. The company's legal advisor has inspected the land title deeds of the buildings occupied and used by the company (Sap Rung Rueang-40 and Sap Rung Rueang-Cosmetics). It was found that these buildings were likely constructed by a reputable project developer, making it probable that they obtained proper construction permits and occupancy certificates. Furthermore, since the company began using the buildings, it has never received any complaints or encountered any issues regarding their use due to a lack of construction permits or occupancy permits. Regarding the company's inability to present copies of construction permits and building completion certificates for buildings purchased or leased from third parties, the company's legal advisor is of the opinion that the company's lack of copies of construction permits and/or building completion certificates for buildings it did not construct itself does not constitute a legal offense. This is because the company, as the transferee of ownership (under a sale and purchase agreement) or the recipient of possession rights (under a lease agreement), has no legal obligation to obtain construction permits and/or building completion certificates. However, the company has already proceeded to obtain Type 4 factory operating licenses (Ror Ngor 4) for both factories. These licenses have been granted by the Department of Industrial Works of Samut Prakan Province, allowing the company to fully conduct its business of manufacturing both dietary supplements and cosmetics.
Therefore, the company has an approach to manage risks arising from distribution costs.
The company has prepared an annual budget plan to control distribution costs and monitors to ensure that distribution costs align with the sales and inventory clearance budget and do not exceed the allocated budget. The company regularly compares the monthly budget plan against actual distribution costs. Traditionally, the company's sales primarily focused on offline channels, mainly through TV Home Shopping. The majority of these expenses were promotional costs paid by the company to its partners (TV Home Shopping). In 2022, the company began to develop and increasingly sell through online channels, a trend that continues to the present. While offline sales primarily involve promotional costs, online sales incur both promotional costs and advertising expenses across various platforms, which are variable costs. The company has established an advertising budget. For marketplaces, a monthly budget is prepared, and participation with each marketplace is considered. A spending limit is set for each account according to the company's approval and operational authority. Expenses must be controlled and monitored to remain within the company's specified criteria, and the results must be reported to management. Furthermore, for advertising budgets in Digital Marketing channels such as Facebook, TikTok, and Google, etc., sales and expense budgets are prepared for each responsible Facebook page, and a summary is provided to management, in accordance with the company's approval and operational authority. Subsequently, spending limits are assigned to relevant employees. The company monitors revenue generated from advertising campaigns to control expenses within the company's specified criteria. Daily reports are then prepared for relevant personnel, based on their approval authority, before being presented to management on a daily basis. A summary report of advertising expenditures is also prepared monthly.
affects operating performance, requiring the recording of expected credit losses.
The company manages risk by establishing operational procedures for debt collection. Debtor information will be analyzed to identify outstanding debtors, and the responsible sales operations staff will be assigned to inquire about and collect the debts. To mitigate the risk of the company being unable to collect payments from contract manufacturing (OEM) clients, the company will collect a 50% deposit before production and another 50% before delivery (in accordance with Sales Operations OEM Sales Policy No. PCSO008). For other offline sales channels, such as TV Home Shopping or pharmacy channels (OTC), the company's collection policy follows the aforementioned procedures. Initially, the finance department staff will follow up with debtors whose payments are due. If payment is not received, the sales operations staff will be informed to assist in expediting collection. Furthermore, at the end of each month, a report will be submitted to management regarding overdue accounts. If overdue debts remain unpaid, the company will consider withholding further sales. The finance department staff will then issue a written notice. If the debt remains unpaid, the legal department will initiate legal proceedings. All actions will comply with the Debt Collection Act B.E. 2558 (2015).
The company is likely to increase imports of raw materials from abroad due to lower costs, which will consequently increase such risks.
The company closely monitors foreign currency trends. Should there be a tendency for currency values to change in a manner that severely impacts the company, or if the company engages in significant foreign currency-denominated commercial transactions, the company may consider acquiring a portion of forward foreign exchange contracts to mitigate potential risks. The currency utilized by the company for settling foreign debts is the US Dollar. Furthermore, the company reported a profit (loss) from exchange rates in 2022, 2023, 2024, and 2025 amounting to 0.04 million Baht, 0.06 million Baht, (0.29) million Baht, and 0.05 million Baht, respectively.
Shareholder Risk
Mr. Parkin Kittiparnuwat, the company's largest shareholder, can determine management policies and object to resolutions of the shareholders' meeting that, by law or the company's articles of association, require a 3/4 majority vote of the total votes of shareholders attending the meeting and having the right to vote, such as a capital increase, capital decrease, or the sale or transfer of part or all of the business.
The company has appointed 3 independent directors out of a total of 9 directors to participate in board meetings, serving to scrutinize and provide checks and balances on the company's executive management. These individuals possess expertise in accounting and finance, legal matters, and medical fields, and are also responsible for considering and approving various items before presenting them to the shareholders' meeting. This measure is implemented to assure shareholders that the company's internal management will be conducted transparently and for the benefit of the company.
may affect the trading price of shares on the Stock Exchange, whereby the Company cannot definitively predict or guarantee the impact (if any) on the share price at that specific time.
Risk management process, as filed
| Details | Year 2025 |
|---|---|
| - The Risk Management Working Group met to summarize the results of risk management from the past year and prepare the current year's risk management plan. | February |
| - Risk Management Working Group reports to the Audit Committee, 1st meeting | |
| - Relevant parties in each department implement the risk management plan. | |
| - Risk Management Working Group reports to the Audit Committee, 2nd meeting | May 8 |
| - Meeting to monitor the progress of enterprise and departmental risk management operations | August 4 |
| - Risk Management Working Group reports to the Audit Committee, 3rd meeting | August 11 |
| - Annual Meeting: - Acknowledging the progress of enterprise and departmental risk management operations - Review of the Risk Management Committee Charter | November 4 |
| - Risk Management Working Group reports to the Audit Committee, 4th meeting | November 11 |
| Details | Year 2026 |
| - The Risk Management Working Group met to summarize the results of risk management from the past year and prepare the current year's risk management plan. | February 27 |
| - Risk Management Working Group reports to the Audit Committee, 1st meeting | |
| - Relevant parties in each department implement the risk management plan. | |
| - Risk Management Working Group reports to the Audit Committee, 2nd meeting | May 11 |
| - Meeting to monitor the progress of enterprise and departmental risk management operations | August 3 |
| - Risk Management Working Group reports to the Audit Committee, 3rd meeting | August 10 |
| - Annual Meeting: - Acknowledging the progress of enterprise and departmental risk management operations - Review of the Risk Management Working Group Charter | November 4 |
| - Risk Management Working Group reports to the Audit Committee, 4th meeting | November 11 |
| Details | Year 2027 |
| - The Risk Management Working Group met to summarize the results of risk management from the past year and prepare the current year's risk management plan. | February |
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.
